Discover how AI chatbots are reshaping weight-loss planning with precision and variety, yet face challenges in balancing macronutrients for optimal health.
Subclinical Afib Caught on Cardiac Devices Might Be Better Left Alone
AMSTERDAM — Edoxaban (Savaysa) didn’t improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial